All Stories

  1. M1-derived extracellular vesicles polarize recipient macrophages into M2-like macrophages and alter skeletal muscle homeostasis in a hyper-glucose environment
  2. Senescent Endothelial Cells Sustain Their Senescence-Associated Secretory Phenotype (SASP) through Enhanced Fatty Acid Oxidation
  3. PCOS and vitamin D: a clinical appraisal
  4. An aqueous olive leaf extract (OLE) ameliorates parameters of oxidative stress associated with lipid accumulation and induces lipophagy in human hepatic cells
  5. Editorial: Tumor microenvironment signaling networks in pathophysiology and therapeutics
  6. Androgen receptor in breast cancer: The “5W” questions
  7. Downstream Signaling of Inflammasome Pathway Affects Patients’ Outcome in the Context of Distinct Molecular Breast Cancer Subtypes
  8. Editorial: Lipid Orchestrated Signaling in Physiology and Pathology
  9. The Biological Relevance of NHERF1 Protein in Gynecological Tumors
  10. Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion
  11. Nutritional Regimes Enriched with Antioxidants as an Efficient Adjuvant for IBD Patients under Infliximab Administration, a Pilot Study
  12. Tumor Microenvironment Signaling Networks in Pathophysiology and Therapeutics
  13. Oxidative Stress and Multi-Organel Damage Induced by Two Novel Phytocannabinoids, CBDB and CBDP, in Breast Cancer Cells
  14. Differential Glycosylation Levels in Saliva from Patients with Lung or Breast Cancer: A Preliminary Assessment for Early Diagnostic Purposes
  15. Oleoylethanolamide Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in High-Fat Diet-Fed Rats
  16. Investigation on the Composition of Agarose–Collagen I Blended Hydrogels as Matrices for the Growth of Spheroids from Breast Cancer Cell Lines
  17. Protein Kinase C Activation Drives a Differentiation Program in an Oligodendroglial Precursor Model through the Modulation of Specific Biological Networks
  18. Editorial: Dietary Antioxidants and Metabolic Diseases
  19. Vitamin D: Mechanism of Action and Biological Effects in Uterine Fibroids
  20. Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis
  21. Flow Cytometry Analysis of Circulating Extracellular Vesicle Subtypes from Fresh Peripheral Blood Samples
  22. Microbiota-Derived Metabolites in Tumor Progression and Metastasis
  23. Dystocia, Uterine Healing and Uterine Innervation: An Unexplored Intersection
  24. Alternative proteins are functional regulators in cell reprogramming by PKA activation
  25. Extracellular Vesicles as Signaling Mediators and Disease Biomarkers across Biological Barriers
  26. The Biological Impact of Ulipristal Acetate on Cellular Networks Regulating Uterine Leiomyoma Growth
  27. Adrenergic and Cholinergic Uterine Innervation and the Impact on Reproduction in Aged Women
  28. A Hidden Human Proteome Signature Characterizes the Epithelial Mesenchymal Transition Program
  29. 3D-microenvironments initiate TCF4 expression rescuing nuclear β-catenin activity in MCF-7 breast cancer cells
  30. Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling
  31. The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression
  32. The multiverse nature of epithelial to mesenchymal transition
  33. Lipid profiling of parkin-mutant human skin fibroblasts
  34. Distinct Protein Expression Networks are Activated in Microglia Cells after Stimulation with IFN-γ and IL-4
  35. Oxidative Molecular Mechanisms Underlying Liver Diseases: From Systems Biology to the Personalized Medicine
  36. NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus
  37. A specific lipid metabolic profile is associated with the epithelial mesenchymal transition program
  38. Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes
  39. Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet
  40. An SPR based immunoassay for the sensitive detection of the soluble epithelial marker E-cadherin
  41. Uterine Fibroids: From Molecular Oncology to Reproduction
  42. Quartz Crystal Microbalance as Cell-Based Biosensor to Detect and Study Cytoskeletal Alterations and Dynamics
  43. β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy
  44. Proteomic expression profile of injured rat peripheral nerves revealed biological networks and processes associated with nerve regeneration
  45. The Many-Faced Program of Epithelial–Mesenchymal Transition: A System Biology-Based View
  46. Uterine-Preserving Operative Therapy of Uterus Myomatosus
  47. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease
  48. β-Catenin Knockdown Affects Mitochondrial Biogenesis and Lipid Metabolism in Breast Cancer Cells
  49. Abstract 367: Trop-2 activates a dormant Na+/K+-ATPase/PKCα/CD9/ezrin signaling axis to override the basal growth program of cancer cells
  50. Platinum-induced mitochondrial DNA mutations confer lower sensitivity to paclitaxel by impairing tubulin cytoskeletal organization
  51. The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma
  52. Fats for thoughts: An update on brain fatty acid metabolism
  53. Lipid profiling of parkin -mutant human skin fibroblasts
  54. Resveratrol Modulation of Protein Expression in parkin-Mutant Human Skin Fibroblasts: A Proteomic Approach
  55. Anticancer effects of novel resveratrol analogues on human ovarian cancer cells
  56. Neurotransmitters and Neuropeptides Expression in the Uterine Scar After Cesarean Section
  57. A Proteomic Analysis of Human Uterine Myoma
  58. A Qualitative and Quantitative Study of the Innervation of the Human Non Pregnant Uterus
  59. Angiogenesis and Vascularization of Uterine Leiomyoma: Clinical Value of Pseudocapsule Containing Peptides and Neurotransmitters
  60. Laminin and Collagen IV: Two Polypeptides as Marker of Dystocic Labor
  61. Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics
  62. Comparative proteomic profiling of Hodgkin lymphoma cell lines
  63. Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients
  64. Frontispiece
  65. Polymer-Coated Magnetic Nanoparticles for Curcumin Delivery to Cancer Cells
  66. Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells
  67. Transgenic Plants as Low-Cost Platform for Chemotherapeutic Drugs Screening
  68. Selective genetic analysis of myoma pseudocapsule and potential biological impact on uterine fibroid medical therapy
  69. Genetic and Genomics of Uterine Myomas
  70. A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target
  71. Cytoskeletal alterations of parkin-mutant human primary fibroblasts
  72. Molecular and biochemical alterations in epithelial to mesenchymal transition
  73. Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target
  74. Antitumor activity of the dietary diterpene carnosol against a panel of human cancer cell lines
  75. Management of Hereditary Ovarian–Breast Cancer
  76. The opioid neuropeptides in uterine fibroid pseudocapsules: a putative association with cervical integrity in human reproduction
  77. Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature
  78. The mRNA-HPV Test Utilization in the Follow Up of HPV Related Cervical Lesions
  79. Efficient stabilization of natural curcuminoids mediated by oil body encapsulation
  80. New bioactive compounds of vegetable sources in cancer therapy
  81. Time is moving fast
  82. The Impact of Proteomics in the Understanding of the Molecular Basis of Paclitaxel-Resistance in Ovarian Tumors
  83. Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer
  84. Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells
  85. Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells
  86. New molecules in the ovarian cancer therapy
  87. Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells
  88. Epithelial–mesenchymal transition in ovarian cancer
  89. Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal
  90. IFN-β reverses the lipopolysaccharide-induced proteome modifications in treated astrocytes
  91. Biomolecular Pathogenesis of Borderline Ovarian Tumors: Focusing Target Discovery Through Proteogenomics
  92. Age-related pelvic floor modifications and prolapse risk factors in postmenopausal women
  93. HPV Viral Activity by mRNA-HPV Molecular Analysis to Screen the Transforming Infections in Precancer Cervical Lesions
  94. Biomechanical and proteomic analysis of INF- β-treated astrocytes
  95. Retraction Notice: An Outlook on Ovarian Cancer and Borderline Ovarian Tumors: Focus on Genomic and Proteomic Findings
  96. MALDI Imaging Mass Spectrometry: STATE OF THE ART TECHNOLOGY IN CLINICAL PROTEOMICS
  97. PBMCs protein expression profile in relapsing IFN-treated multiple sclerosis: A pilot study on relation to clinical findings and brain atrophy
  98. Effects of visceral peritoneal closure on scar formation at cesarean delivery
  99. Cytomechanical and topological investigation of MCF-7 cells by scanning force microscopy
  100. Closure Versus Non-Closure of the Visceral Peritoneum (VP) in Patients with Gestational Hypertension—An Observational Analysis
  101. Myoma pseudocapsule: A distinct endocrino-anatomical entity in gynecological surgery
  102. Endometriosis Management: Workflow on Genomics and Proteomics and Future Biomolecular Pharmacotherapy
  103. Proteomic map of peripheral blood mononuclear cells
  104. Abdominopelvic tuberculosis in gynaecology: Laparoscopical and new laboratory findings
  105. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: A clinical review
  106. Ovarian Cancer Biomarkers: A Focus on Genomic and Proteomic Findings
  107. Human papillomavirus genital infection in modern gynecology: genetic and genomic aspects
  108. Emergency surgical procedure for failed methotrexate treatment of cervical pregnancy: A case report